Home/Filings/4/0001104659-24-033165
4//SEC Filing

Dubovsky Filip 4

Accession 0001104659-24-033165

CIK 0001000694other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 9:40 PM ET

Size

8.8 KB

Accession

0001104659-24-033165

Insider Transaction Report

Form 4
Period: 2024-03-07
Dubovsky Filip
President, R&D
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-07+19,44473,226 total
  • Tax Payment

    Common Stock

    2024-03-07$5.61/sh9,392$52,68963,834 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-0719,4440 total
    Common Stock (38,886 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
  • [F2]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date

Issuer

NOVAVAX INC

CIK 0001000694

Entity typeother

Related Parties

1
  • filerCIK 0001977361

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 9:40 PM ET
Size
8.8 KB